NR1H3 and metabolic dysfunction-associated steatotic liver disease: This suggests that changes in LXRα phosphorylation could alter pre-clinical NAFLD progression and emphasizes a role for Ser196-LXRα phosphorylation in the regulation of these remodeling pathways.